Parametric Portfolio Associates’s Corcept Therapeutics CORT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$5.67M Buy
251,740
+35,166
+16% +$792K ﹤0.01% 1763
2021
Q4
$4.29M Sell
216,574
-35,438
-14% -$702K ﹤0.01% 1974
2021
Q3
$4.96M Buy
252,012
+31,166
+14% +$613K ﹤0.01% 1830
2021
Q2
$4.86M Sell
220,846
-15,918
-7% -$350K ﹤0.01% 1869
2021
Q1
$5.63M Buy
236,764
+7,018
+3% +$167K ﹤0.01% 2083
2020
Q4
$6.01M Sell
229,746
-18,892
-8% -$494K ﹤0.01% 1952
2020
Q3
$4.33M Buy
248,638
+33,982
+16% +$592K ﹤0.01% 1999
2020
Q2
$3.61M Buy
214,656
+19,909
+10% +$335K ﹤0.01% 2111
2020
Q1
$2.32M Buy
194,747
+42,565
+28% +$506K ﹤0.01% 2284
2019
Q4
$1.84M Buy
152,182
+35,887
+31% +$434K ﹤0.01% 2744
2019
Q3
$1.64M Buy
116,295
+37,688
+48% +$533K ﹤0.01% 2760
2019
Q2
$876K Sell
78,607
-74,730
-49% -$833K ﹤0.01% 3110
2019
Q1
$1.8M Sell
153,337
-28,042
-15% -$329K ﹤0.01% 2716
2018
Q4
$2.42M Buy
181,379
+29,395
+19% +$393K ﹤0.01% 2451
2018
Q3
$2.13M Sell
151,984
-4,384
-3% -$61.5K ﹤0.01% 2666
2018
Q2
$2.46M Sell
156,368
-43,377
-22% -$682K ﹤0.01% 2541
2018
Q1
$3.29M Buy
199,745
+38,548
+24% +$634K ﹤0.01% 2245
2017
Q4
$2.91M Buy
161,197
+16,433
+11% +$297K ﹤0.01% 2337
2017
Q3
$2.79M Buy
144,764
+53,381
+58% +$1.03M ﹤0.01% 2343
2017
Q2
$1.08M Buy
91,383
+48,592
+114% +$573K ﹤0.01% 2940
2017
Q1
$469K Sell
42,791
-3,384
-7% -$37.1K ﹤0.01% 3220
2016
Q4
$335K Buy
46,175
+31,018
+205% +$225K ﹤0.01% 3368
2016
Q3
$99K Buy
15,157
+1,517
+11% +$9.91K ﹤0.01% 3680
2016
Q2
$74K Buy
13,640
+575
+4% +$3.12K ﹤0.01% 3752
2016
Q1
$61K Buy
13,065
+1,638
+14% +$7.65K ﹤0.01% 3913
2015
Q4
$57K Buy
11,427
+301
+3% +$1.5K ﹤0.01% 3903
2015
Q3
$42K Sell
11,126
-6,144
-36% -$23.2K ﹤0.01% 3244
2015
Q2
$104K Sell
17,270
-38,685
-69% -$233K ﹤0.01% 3872
2015
Q1
$313K Buy
55,955
+36
+0.1% +$201 ﹤0.01% 3539
2014
Q4
$168K Buy
55,919
+663
+1% +$1.99K ﹤0.01% 3824
2014
Q3
$148K Buy
+55,256
New +$148K ﹤0.01% 3673
2014
Q2
Sell
-29,555
Closed -$129K 3736
2014
Q1
$129K Hold
29,555
﹤0.01% 3711
2013
Q4
$95K Buy
29,555
+6,139
+26% +$19.7K ﹤0.01% 3731
2013
Q3
$37K Sell
23,416
-7,165
-23% -$11.3K ﹤0.01% 3788
2013
Q2
$53K Buy
+30,581
New +$53K ﹤0.01% 3655